Good Medicine Podcast

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Josh Miller, CEO of Biologic Input Output Systems, Inc. (BIOS), to talk about groundbreaking work at the intersection of neuroscience, engineering, and human connection.

BIOS develops advanced neural interface technology that allows the nervous system to communicate directly with machines. Their work focuses on restoring movement, sensation, and function by translating brain signals into action and, in some cases, returning sensory feedback back to the brain.

In this conversation, Josh shares deeply moving stories from clinical trials, including a woman who was able to feel and control a virtual hand simply by thinking about it after years without an arm. He also explains why BIOS chose to start with upper limb prosthetics, one of the most complex challenges in neurotechnology, and what it means for people who have lost the ability to do simple but meaningful things like holding a loved one’s hand.

The episode also explores how BIOS technology could help block pain signals in the nervous system, opening the door to entirely new approaches to pain management.

This is a conversation about science that restores dignity, independence, and hope.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

BIOS

For individuals interested in connecting directly with BIOS: https://www.biologicinputoutputsystems.com/registry

LinkedIn: https://www.linkedin.com/company/biologic-input-output-systems/

Instagram: @biologicinputoutputsystems

Website: https://www.biologicinputoutputsystems.com

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Jim Hotaling and Dr. Brad Cairns from Paterna Biosciences to talk about a new way of thinking about male infertility.

Dr. Brad Cairns explains that in many cases, stem cells themselves are not the root of the problem. Instead, the issue lies in the supporting or chaperoning cells that guide stem cells through normal development. Paterna’s work focuses on restoring that developmental process rather than replacing cells outright.

The conversation also explores how Paterna is developing approaches to help men with infertility at many different stages, offering options even when traditional treatments have failed. Dr. Jim Hotaling shares the deeply personal side of this work, reflecting on his role in delivering life altering news to families and how that responsibility drives his commitment to building better solutions.

This episode blends cutting edge science with the human reality behind infertility and why progress in this space matters so much.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss take a hard look at Alzheimer’s disease through the lenses of caregiving, economics, and the future of medicine.

They discuss the immense burden Alzheimer’s places on families and the economy, why treating the disease after it has fully developed may be too late, and how precision medicine could help identify people at risk long before symptoms appear.

The conversation also looks ahead to what the next phase of Alzheimer’s research may focus on, shifting from reacting to damage toward preserving brain function decades earlier. This episode is about understanding the full cost of Alzheimer’s and why prevention may be the most important step forward.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss look ahead to what 2026 could bring for medicine, public health, and drug development.

They discuss early data suggesting major reductions in tuberculosis progression, how inflammation may reshape the way we treat cardiovascular disease, and why AI guided precision clinical trials are likely to become the norm. These changes could dramatically reduce cost, speed up development timelines, and improve success rates across medicine.

This conversation is about where the field is headed next and why the coming years may look very different from the last decade.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Ryan Morley from Springtide Ventures to talk about early stage investing, entrepreneurship, and what it takes to build companies that truly improve human health.

Ryan explains how Springtide focuses on partnering with early stage companies in health and life science technology, working closely with founders as they build and scale. Their approach is not just about capital, but about long term collaboration and helping companies navigate the complex healthcare ecosystem.

The conversation also dives into purpose driven entrepreneurship. Ryan shares why so many founders he works with are motivated by deeply personal experiences and how that purpose shapes stronger companies. They close by discussing why understanding the end customer and aiming to elevate human health, not just incrementally improve healthcare, is critical for lasting impact.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

As 2025 comes to a close, Dr. David Bearss looks back on some of the most impactful conversations from the Good Medicine Podcast this year.

This special recap episode highlights key moments from episodes on reverse brain aging, AI and innovation, live conversations at BYU, the science of exercise, precision medicine and cancer innovation, mental health, the human side of science, and reimagining healthcare and education.

From cutting edge research to deeply human stories, these conversations reflect what Good Medicine is all about: thoughtful science, honest discussion, and a focus on improving health for individuals and communities.

If you are new to the podcast, this is a great place to start. If you have been listening all year, this episode brings together the moments that defined 2025.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Jeremiah Bearss for a careful and educational discussion on vaccines, how they work, and how scientific evidence should be evaluated.

They walk through the history of vaccines, how immune protection is created, and how vaccines have shaped public health over time. The conversation also addresses COVID-19, common concerns around vaccine safety, and the importance of properly interpreting data when looking at autism prevalence.

Rather than relying on headlines or assumptions, this episode focuses on how science actually works, what the evidence shows, and why critical thinking matters when discussing complex health topics.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss hosts a special panel recorded at the BioUtah Life Science Summit. Joining him are Dr. Mark Ott, Dean of the BYU School of Medicine, and Dr. Bob Carter, physician executive at University of Utah Health.

Together, they discuss some of the biggest challenges and opportunities facing healthcare in Utah. The conversation covers statewide genomics efforts, the growing strain on hospital capacity, the rise of at home care models, and what the next generation needs to understand about the future of biotechnology and medicine.

This episode offers a direct look into the issues that will shape healthcare over the next decade and how Utah is preparing for the coming wave of aging citizens and increasing medical need.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Life Science Summit. The panel brings together leaders from across the industry, including Hariprasad Vankalapati of Biolexis, Alison O’Mahony of Seek Labs, and Ian Quigley of Leash Bio.

Together, they discuss how artificial intelligence is beginning to reshape drug discovery, diagnostics, and the way companies make decisions. The conversation highlights how AI helps teams understand both positive and negative data, identify emerging threats, and improve the success rate of bringing new drugs to market. This panel offers a grounded look at how AI is being used in real life science organizations today and what the future may hold.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss speaks with Dr. Karson Kump of Aditum Bio, an organization focused on advancing treatments for unmet medical needs by guiding programs through development with a disciplined, data-driven approach.

Dave opens the discussion by explaining how business development in life sciences is really about resource allocation. Scientists often follow what interests them, but companies must stay focused on what patients actually need and where the biggest gaps in medicine still exist.

Karson shares how spending enough time in science humbles you. He explains that good decisions come from yielding to the science and letting objective data lead the way. At the same time, choosing to take a program outside your own company and into the world of partnerships can feel risky, even though it may be the best path forward.

The conversation ends with Dave reflecting on ego, humility and delegation. In a field filled with smart, driven people, he has learned that real success comes from knowing when to step back and let someone who is better at a specific task take the lead.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠